|  | 
| Mechanismμ opioid receptor inverse agonists | 
|  | 
| Originator Org.- | 
|  | 
| Inactive Indication- | 
| Drug Highest PhaseApproved | 
| First Approval Ctry. / Loc.China | 
| First Approval Date12 Dec 2003 | 
100 Clinical Results associated with Qinghai Pharmaceutical (Group) Co., Ltd.
0  Patents (Medical) associated with Qinghai Pharmaceutical (Group) Co., Ltd.
100 Deals associated with Qinghai Pharmaceutical (Group) Co., Ltd.
100 Translational Medicine associated with Qinghai Pharmaceutical (Group) Co., Ltd.